Reports

296 Results (Page 4 of 12)

South Africa Markets Research Reports

Pharmaceuticals

South Africa Rheumatoid Arthritis Drugs Market Analysis

South Africa Rheumatoid Arthritis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rheumatoid Arthritis Drugs market is growing globally due to the growing aging population, increasing prevalence of rheumatoid arthritis, growing development in biologics, advancements in treatment options, increasing investment in research and development activities, increasing patient awareness and diagnosis and increased technological advancements. Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH., Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca, Ampio Pharmaceuticals Inc., Lilly, Fresenius Kabi AG, Bayer AG, Casper Pharma, Dr. Reddy's Laboratories Ltd., Norbrook.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Rituximab Biosimilars Market Analysis

South Africa Rituximab Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rituximab biosimilars market is growing globally due to the government initiatives, increased healthcare expenditure, increase in biopharmaceutical R&D expenditure, low cost of biosimilars, aging population, increase in healthcare access, patent expiry of reference product, rising prevalence of chronic diseases and growing acceptance and confidence for biosimilars. Teva Pharmaceuticals, Novartis AG, Pfizer, BIOCAD, and Shanghai Henlius Biotech, Inc. are the key global market players in Rituximab Biosimilars Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Rotavirus Vaccine Market Analysis

South Africa Rotavirus Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rotavirus Vaccine market is growing globally due to the rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, international support from world health organization. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Sarcoma Drugs Market Analysis

South Africa Sarcoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Sarcoma Drugs market is growing globally due to the increasing incidence and prevalence of sarcoma, advances in research and development, development of targeted therapies, collaboration and partnerships between research organizations and pharmaceutical companies, patient advocacy and awareness programmes and support from regulatory authorities. Johnson & Johnson Private Limited, Abbott, AbbVie Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Pfizer Inc, Mylan N.V., Bristol-Myers Squibb Company, GSK plc., Bayer AG are the key market players in global sarcoma drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Seasonal Flu Vaccine Market Analysis

South Africa Seasonal Flu Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Seasonal Flu Vaccine market is growing globally due to the rising awareness of the necessity of getting the flu shot and the initiatives to expand immunization programmes, expanding government support and focus on seasonal flu vaccination, robust research and development activities with strong pipeline candidates, high influenza rates among children owing to demand for pediatric vaccines. GlaxoSmithKline, AstraZeneca, Seqirus, Pfizer, Novartis, Johnson & Johnson, Daiichi Sankyo Company, Bharat Biotech International Limited, Mitsubishi Tanabe Pharma Corporation are the key global market players in Seasonal flu vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa SGLT2 Inhibitor Market Analysis

South Africa SGLT2 Inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. SGLT2 Inhibitor market is growing globally due to the rising prevalence of type 2 diabetes, Efficacy and Safety Profile of these drugs is good in treating type 2 diabetes, promoting weight loss and protecting from cardiovascular diseases, expanded indications of these drugs to include management of heart failure with reduced ejection fraction and chronic kidney disease, advancements in drug development. Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals and Astellas are the key market players operating globally.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Skin Tightening Market Analysis

South Africa Skin Tightening Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Skin Tightening market is growing globally due to the rising demand for minimally invasive cosmetic operations, increased interest in aesthetic procedures, rise in healthcare expenditures, improvements in skin tightening technology and an ageing population seeking skin rejuvenation procedures, the creation of cutting-edge skin tightening technologies, as well as strategic alliances or partnerships between major firms. Merz Pharma, ALLERGAN, BISON MEDICAL, Pollogen, BRERA MEDICAL TECHNOLOGIES S.R.L., Cutera, Opatra Ltd, Venus Concept, Alma Lasers, Beijing Winkonlaser Technology Limited, DEKA M.E.L.A. srl, Fotona, ThermiGen, LLC, Hologic, Inc, EINSMED Co. Ltd and Bausch Health Companies Inc. are the key global market players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Sleep Aid Market Analysis

South Africa Sleep Aid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Sleep Aid market is growing globally due to the global population growth, increased consumer awareness of portable sleep apnea devices, rapid adoption of sensors and wearable monitors, rising personal disposable income among the big companies, rising prevalence of sleep disorders, increasing awareness about the importance of healthy sleep, lifestyle changes leading to sleep disturbances, and the growing elderly population. Koninklijke Philips N.V., Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, ResMed, BMC Medical Co., Ltd., SomnoMed, Fisher & Paykel Healthcare Limited, Somnowell, Compumedics Limited, APEX MEDICAL CORP., Inspire Medical Systems, Inc., NIHON KOHDEN CORPORATION, DeVilbiss Healthcare LLC, nox medical, Advanced Brain Monitoring, Inc., Cleveland Medical Devices Inc., Braebon Medical Corporation, and Löwenstein Medical Technology GmbH + Co. KG are the key global market players in Sleep Aid Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Subcutaneous Immunoglobulin Market Analysis

South Africa Subcutaneous Immunoglobulin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Subcutaneous Immunoglobulin market is growing globally due to the Increasing prevalence of chronic and autoimmune diseases, the trend towards providing healthcare in the patient's home, improvements in infusion technology, and the advantages and benefits of subcutaneous delivery, rise in the prevalence of sedentary lifestyle due to urbanization and stress. Baxter, Biotest AG., China Biologic Products Holdings, Inc., CSL Limited, Grifols, S.A., Kedrion S.p.A, Octapharma, GREEN CROSS CORP, Coram LLC, Momenta Pharmaceuticals, Option Care Enterprises, Inc., ADMA Biologics, Inc., Gentian Diagnostics AS, Mabtech, J. Mitra & Co. Pvt. Ltd, Cygnus Technologies, Kamada Pharmaceuticals are the key global market players in subcutaneous immunoglobulin market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Supportive Care Agents in Cancer Market Analysis

South Africa Supportive Care Agents in Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Supportive Care Agents in Cancer market is growing globally due to the increasing cancer incidence which causes growth in need for effective supportive care measures to manage treatment-related symptoms and improve patients' quality of life, side effects caused by cancer treatments which require supportive care, growing emphasis on patient-centered care, increased awareness and education among patients and healthcare professionals, support by regulatory bodies and launch of new products. Acacia Pharma Group Plc, Teva Pharmaceuticals Industries Ltd, Fagron Group, KYOWA HAKKO BIO CO., LTD., APR, and F. Hoffmann-La Roche Ltd are the key global market players in supportive care agents in cancer market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Systemic Lupus Erythematosus Market Analysis

South Africa Systemic Lupus Erythematosus Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Systemic Lupus Erythematosus market is growing globally due to the rise in the prevalence of systemic lupus erythematosus across the world, increasing geriatric population and rising healthcare expenditure, advances in research and development for introduction of novel therapies, Growing Awareness and Diagnosis and Government Initiatives and Support. GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Bristol Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, AbbVie Inc. are the key global market players in Systemic Lupus Erythematosus Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa T-Cell Lymphoma Market Analysis

South Africa T-Cell Lymphoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. T-Cell Lymphoma market is growing globally due to the High lymphoma cancer incidence rate, rising healthcare expenditure, rising number of geriatric population, increasing risk of lymphoma due to autoimmune disorders, high disposable income, advancement in T-cell lymphoma-specific therapies, unmet medical needs, advances in diagnostic techniques and increasing utilization of immunotherapies. Bristol Myers Squibb Company, Novartis AG, Kyowa Kirin Co., Ltd., Merck & Co., Inc., Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., BeiGene, Ltd., and Epizyme, Inc. are the key global market players in T-Cell Lymphoma Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Tetanus Toxoid Vaccine Market Analysis

South Africa Tetanus Toxoid Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tetanus toxoid vaccine market is growing globally due to the government initiatives like mandatory immunization programs, increasing awareness among individuals and healthcare professionals about the importance of tetanus vaccination, improved healthcare infrastructure which has facilitated the distribution and administration of tetanus toxoid vaccines, technological advancements in vaccine manufacturing techniques including improved purification methods and rising Incidence of tetanus cases. Sanofi Pasteur, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, Biological E. Limited are the key global market players in tetanus toxoid vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Thin Film Drugs Market Analysis

South Africa Thin Film Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Thin Film Drugs market is growing globally due to the pediatric and geriatric applications as they have difficulty in swallowing conventional tablets, technological advancements like development of innovative film-forming materials, improved manufacturing processes and enhanced drug delivery systems, better patient convenience and compliance thereby improving medication adherence, rapid drug absorption and improved bioavailability and increase in research and development activities. Pfizer Inc., Novartis AG, GlaxoSmithKline plc (GSK), Johnson & Johnson Services, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., ZIM Laboratories Ltd., Indivior PLC, MonoSol Rx (A Subsidiary of MonoSol LLC), LTS Lohmann Therapie-Systeme AG, APR Applied Pharma Research s.a., CURE Pharmaceutical Holding Corp. are the key global market players in thin film drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa TNF Inhibitors Market Analysis

South Africa TNF Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. TNF Inhibitors market is growing globally due to the rising prevalence of autoimmune diseases like rheumatoid arthritis, psoriasis, psoriatic arthritis, inflammatory bowel disease for which TNF Inhibitors are used. Increase in number of research and development activities in tumor necrosis factor (TNF) inhibitor drugs, increasing acceptance of biologic therapies, expanding indications of TNF Inhibitors like dermatologic disorders, ophthalmic diseases, and neurological disorders and growth in ageing population. AbbVie Inc., Amgen Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer Inc., Novartis International AG, UCB S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Samsung Bioepis Co., Ltd., Sandoz International GmbH are the key global market players in TNF Inhibitors Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Top Selling Biologics Market Analysis

South Africa Top Selling Biologics Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing research and development activities and favorable reimbursement policies act as market growth drivers. Some of the major players in this market are Roche/Genentech, Johnson & Johnson, AbbVie, Amgen etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Topical Drugs Delivery Market Analysis

South Africa Topical Drugs Delivery Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical drugs delivery market is growing globally due to the rising incidence and prevalence of various skin disorders, such as acne, eczema, psoriasis, and dermatitis, advancements in formulation technologies like nano emulsions, liposomes, micelles, and transdermal patches, patient preference for non-invasive treatment that minimize side effects and offer localized therapy, growing aging population, rising demand for dermatological cosmetics due to focus on personal grooming, increased research and development activities and favorable regulatory environments. Johnson & Johnson Private Limited, Nestlé India Ltd., Novartis AG, GlaxoSmithKline plc, Bausch Health Companies Inc., Merck & Co Inc., Bayer AG, Hisamitsu Pharmaceutical Co.,Inc., Glenmark Pharmaceuticals Limited are the key global market players in topical drugs delivery market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Topical Pain Relief Market Analysis

South Africa Topical Pain Relief Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical Pain Relief market is growing globally due to the increase in incidence and prevalence of Chronic pain conditions such as arthritis, back pain, and musculoskeletal disorders, growing preference for non-opioid pain management due to addictive nature of opioid medications, ease of use and convenience of topical pain relief products, expanding product range and innovation, Increasing Consumer Awareness, Over-the-Counter Availability and rising healthcare expenditure. Advacare Pharma, GlaxoSmithKline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd are the key global market players in topical pain relief market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Transdermal Skin Patches Market Analysis

South Africa Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Transthyretin Amyloidosis (ATTR) Market Analysis

South Africa Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Type 1 Diabetes Mellitus Drugs Market Analysis

South Africa Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Type 2 Diabetes Mellitus Drugs Market Analysis

South Africa Type 2 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 2 Diabetes Mellitus Drugs market is growing globally due to the increasing prevalence of Type 2 diabetes, growing awareness and diagnosis about the disease, advancements in drug therapies, rising geriatric population, government initiatives and healthcare policies, technological advancements in drug delivery, increasing research and development activities and rising healthcare infrastructure. Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Novartis International are the key global market players in type 2 Diabetes Mellitus Drugs Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Tyrosine Kinase Inhibitors Market Analysis

South Africa Tyrosine Kinase Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tyrosine Kinase Inhibitors market is growing globally due to the Increasing prevalence of cancer, increasing use instead of conventional medicines due to their benefits, including the simplicity of oral administration, the capacity to target various cellular survival pathways, and the surge in demand for novel medications. The market is also influenced by an increase in pharmaceutical company investment and the utilization of cell processes to control different cell activities in cancer. Additionally, the market for tyrosine kinase inhibitors is positively impacted by increase in healthcare spending, awareness, population growth, increased healthcare infrastructure, and improvements in cancer treatments. F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., and Johnson & Johnson Services, Inc are the key global market players in tyrosine kinase inhibitors market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Ulcerative Colitis Market Analysis

South Africa Ulcerative Colitis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ulcerative Colitis market is growing globally due to the increasing prevalence of ulcerative colitis, advancements in treatment options like introduction of biologic therapies, such as anti-TNF agents, anti-integrin agents and JAK inhibitors, rising awareness and diagnosis about disease, personalized medicine approaches, research and development initiatives, collaborations and partnerships between pharmaceutical companies and academic institutions. Johnson and Johnson, AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc. are the key global market players in ulcerative colitis market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Unresectable Hepatocellular Carcinoma Market Analysis

South Africa Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up